Atlas Trials

Locally Advanced Solid Tumors

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced Solid Tumors

RecordFirmDate
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations (NCT04094610)Turning Point Therapeutics, Inc.2020-03-12
Imaging of Advanced Tumours Using [131]I-IAZA (NCT03427320)University of Alberta2018-12-01
A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT03646071)NeuPharma, Inc.2018-08-01
This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. (NCT03573544)OBI Pharma, Inc2018-05-07
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (NCT03093116)Turning Point Therapeutics, Inc.2017-03-07
A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors (NCT03059823)Incyte Corporation2016-11-15
Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid Tumors (NCT02045602)Theriva Biologics SL2014-01-01

Track Locally Advanced Solid Tumors automatically

Every clearance here is in the API, with alerts when new ones post.